Director, CEO and President · TriSalus Life Sciences, Inc. · Common Stock
Side
F
Value
$12K
Shares
2,693
Price
$4.38
Executed
Oct 5, 2026
Disclosed
Oct 7, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Oct 5 executedOct 7, 2026 disclosed
TLSI · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Tax withholding — administrative, little informational value
Relative size+1 / 25
$12K reported value · 0.3% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Szela Mary T filed this Form 4 reporting a tax withholding of TLSI on Oct 5, 2026. It became public on Oct 7, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, CEO and President
Szela Mary Tcik:0001410289
Issuer
TriSalus Life Sciences, Inc.cik:0001826667
Revision history · 0
No field has changed since this record was first ingested.
